In part 4 of our interview, we learn more about nipocalimab’s safety profile and how this investigative agent might address ...

J&J IM, which this year marks two decades in Cork, was presented with the award at Cork Chamber’s annual dinner at City Hall ...

Johnson & Johnson (NYSE:JNJ – Get Free Report) was the target of some unusual options trading on Thursday. Stock traders purchased 58,414 call options on the stock. This is an increase of ...

Johnson & Johnson — leaders in healthcare innovation, where treatments are smarter and less invasive, and solutions are ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

The Innovative Medicine segment, formerly known as Pharmaceuticals, has emerged as the primary growth driver for Johnson & Johnson. This division's strong performance is largely attributed to the ...

For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety ...

Johnson & Johnson MedTech, the global leader in heart recovery, is proud to celebrate the inaugural National Heart Recovery ...

Sanctuary Advisors LLC cut its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 10.4% during the fourth quarter, ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...